Bernstein Upgrades Agilon Health to Outperform, Raises Price Target to $125

Benzinga Newsdesk www.benzinga.com Positive 93.5%

Neg 0% Neu 0% Pos 93.5%

Bernstein analyst Lance Wilkes upgrades Agilon Health (NYSE:AGL) from Market Perform to Outperform and raises the price target from $86 to $125.